{"name":"Cho Pharma Inc.","slug":"cho-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTFBxQ29ERVhkMTRBWXFRZ19uQk80Z1d2T1ZNTFh4Z2k0V3FFWkV1OV9fVzBqSFFUaTk2NG5CU2hEOG1iaE1vbWF1NjlBemVEY3poNUIxMFBCVXhQMTJ3YUd4SnI5MEJ1SzdRRDRN?oc=5","date":"2026-04-08","type":"pipeline","source":"히트뉴스","summary":"Yuhan at 100: From Founding Philosophy to Global Innovation - 히트뉴스","headline":"Yuhan at 100: From Founding Philosophy to Global Innovation - 히트뉴스","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNRTlkZWtNdUI1NnJGaFQxZm5YTFJmTS1ieG9aSnVIamVwRElVSjQyOUFxalpMRXhYbWY0MnU3TGFTVXdVay1KZ1gzRTIwWDNsTDBUazV0Q0xSUE9hV0xlWFRSMlM1dkk3UGhzVWp6c2xYYllNNjBMTmY1TndvQkFKa3NXcjFmdHJ4WWJHRHpQRkI4Njh1UzRqTzd1NEhSbC10WFF1U2RLUnExWVdWVUpoM00zN2xZM0RKWTlWM2tn?oc=5","date":"2026-03-25","type":"pipeline","source":"Stock Titan","summary":"Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc. - Stock Titan","headline":"Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE1YcXQydHc0anZxa3Z0N2ZqZm9IVlEyRjVMNnBBYzZuVnVCNFd6VnJUSW1lUzl3TFBVMXJFUFFBZ3VIdkxCREhjcG5VcVQ3Qm5sMWFSRkRON0ZJdGRfb0HSAWNBVV95cUxQUmhRNDF3T2owejZPQ3cxdTBFSXNsSkpOM0ZjSHo1M2dhUGxRcHptNVdINTRIelNCSTZpRHJldUJJcVZETHpvRHVhT1k0NUJndWZuWEJvaFhpODFKWUlIeEhxOFE?oc=5","date":"2026-03-25","type":"pipeline","source":"Bitget","summary":"According to the latest filing with the U.S. Securities and Exchange Commission (SEC), Apimeds Pharmaceuticals US Inc (APUS) has officially announced two key executive appointments: Mr. Cho as Chief E","headline":"According to the latest filing with the U.S. Securities and Exchange Commission (SEC), Apimeds Pharmaceuticals US Inc (A","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-25","type":"pipeline","source":"The Manila Times","summary":"Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc. - The Manila Times","headline":"Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-17","type":"deal","source":"The Manila Times","summary":"Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics - The Manila Times","headline":"Asimov Announces Cell Line Development Partnership with Score Pharma to Advance Biosuperior Antibody Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNYzY2cThpajhSZzl0R2RSa1VZcGx2OEdMT2g2bEloRlV5WkgtQ0hUSXVzR24wWHYwdVZGTUJXLXlYQWJFejl5Rm5LZ0VCREJwTHVGbDFFcDBTRExpRDZ4dmZ5WmZIQlJxVjJudUItQmotMWl1bFpSN3VLZG9yNGw1aDdFdFZuTldiUnprZnZBTElNUzNKSHhibHNGVnlGNTg1WGFRT3puQ0toMkNzWjVlMjNOd2theFFoMW5ieE9saS1IY3l3LTZwT3M4U2tpMzNzaHp6STJFWmRSVG9nSHE4MFlTSUNwWDVIcjlnTGJMUWFVM05iZDdST01XUmVSeGQwMUhR?oc=5","date":"2026-03-09","type":"deal","source":"PR Newswire","summary":"NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes - PR Newswire","headline":"NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxOYkp4R18tR0xkd1B4cmM0dU9PbEd0M250bkNkNjAtZ3BEaGdXTFIxdFU0TmJBN0lITTEyR2QtdE5hUnFqRWYzUWZzblJmVFBUdjk5d0dsQmlPRktZVzdxU1AwRnpKWDlfU3lONzIzaHVDR2dSZUpsY0MxYUdfb25KeFpTVlFlSXRQSDY1QVZLVzRkWHh1WmJQOXFCWUVablFyZG5tVUpmUmRpa1NUZFpDRHJ2RUpvUGhkR1BWakpkQ1o0czNuQWxBR0dXeHpXOTg4N0FfVXV4VnBsMkRNYjNJdEVNNW9pOW1JOWVVLXI2dC1nb3B3STZWNVZ3?oc=5","date":"2026-02-25","type":"regulatory","source":"globenewswire.com","summary":"Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution - globenewswire.com","headline":"Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNVnNiVWRvMXFqUlNIdFVpM2g5eGhKeVVYcFdaS1htM0VHY1l4ZG9aVjNyS19rR3FtQllYZGQ4R3BIZVNyNzF2T1dzM3JaOHVRVGtwbU5OMmtjUmh6aGdOUERRSmV4cTRPc01qbDBFX25SVmFIVTM1WjRDRVlhMGZxRWZNT1YxMG4yNzRSaTU1NEoxZDlrXzZYMm4wNUY?oc=5","date":"2026-01-30","type":"patent","source":"BioWorld News","summary":"Terns Pharmaceuticals patent discloses GIPR antagonists - BioWorld News","headline":"Terns Pharmaceuticals patent discloses GIPR antagonists","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQRVlFU3ZKVzdIQ2dHY0l4bjAxOXdqcXZRNTEzMTBuM0RmRFRsV3MzSUI4ZFl1WHlFRHBlbXgtZ0kzX2NxX09oUF9ZMERkdHFvcEVJVEp2ZlFwWTU4M2ptZlFYVF9XcDk3eW13bVlBZ1NWQWU3UGlOckg3dWZfSnFBV2taUzUwNjZwWkM0SUlNanJGOGdHcHY1MUpDUGpPMjlLUzBxMHhaLTN3ZWdodGQyRzFMLTk?oc=5","date":"2026-01-13","type":"pipeline","source":"BioWorld News","summary":"Crinetics Pharmaceuticals discovers new SSTR2 non-peptide-drug conjugates - BioWorld News","headline":"Crinetics Pharmaceuticals discovers new SSTR2 non-peptide-drug conjugates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFB2Y0E2b2FQOHM2OUFsRFcxVWlHLVRTYTBwSHE2Xy1fbjFDZlZUSWxWa3BiWmotaW9sLVNuOU5hSDI5ZExnOWVManhtWWZyVTZQNC1xd0hrVkxPUW9MdWRpQnoxa19oWVhlMUotTzhB0gFyQVVfeXFMUEZXR2JUck1uS0tKVE5GbGxWQ1l4eEwySUVWam5pelV3bXJlLTMzT3pPeWZHeVN3WGFUcDFLQ0ZfaHhVQ0NmSlJjMUdtSmpGeUdjVUJuTGpDY09qUGVyS2x0Nm5FZ3ppbTBZdnJoNnhha3dR?oc=5","date":"2026-01-08","type":"pipeline","source":"koreabiomed.com","summary":"Samsung Biologics, Celltrion and Big Pharma feed Korea biopharma’s talent pipeline - koreabiomed.com","headline":"Samsung Biologics, Celltrion and Big Pharma feed Korea biopharma’s talent pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE9kcHoyM1NULWhxNExjNmlRX2tTVTE4MjBYcDlFT0pwNFlQQzFBeHdRVDlwSUFZY2txSW5oem9qSkdqWFBZOF8wRXV1VXZLdDBlOElBTXBXVWRZMkV3UlM3X1l3YjM?oc=5","date":"2025-09-19","type":"pipeline","source":"아시아경제","summary":"Yuhan Pharmaceutical Breaks Ground on Osong New Factory... Establishes Global-Standard Advanced Manufacturing Line - 아시아경제","headline":"Yuhan Pharmaceutical Breaks Ground on Osong New Factory... Establishes Global-Standard Advanced Manufacturing Line - 아시아","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFA3UjkwekNBY1RiaXZldjdMVDNzUUVIaE1qRW9OSXRwbGlDcU5QVFdMX1dFTDhZazN4STd6RW1qa0dKV19wZGlSdmU3dFp1NW52WFVaRnp5dUxCOUFudU5sSkhxcGJTbmpvcFVROXh3?oc=5","date":"2025-09-11","type":"pipeline","source":"KED Global","summary":"J Ints Bio unveils 4th-generation targeted anti-cancer drug candidate - KED Global","headline":"J Ints Bio unveils 4th-generation targeted anti-cancer drug candidate","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}